Delivery Order SPE2DB22D3501-SPE2DB25FTC98

Award Date 10/9/24
Potential Completion Date 10/10/24
Potential Value $5.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTC98
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $5,402.40 firm fixed price contract is for the supply of the prescription medication Orilissa 150 mg tablets, with an ultimate completion date of October 10, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies in support of military treatment facilities, veterans' healthcare, and other government healthcare programs.

Generated 1/8/25, 9:31 AM